Course Title: Accelerating Market Access for Medtech Leaders
Date: Tuesday 24 February 2026
Time: 9.00am to 6.00pm
Venue: Duke-NUS Medical School, 8 College Road, Singapore 169857
Application Period: 3 Nov 2025 – 30 Jan 2026
COURSE SYNOPSIS
This practical, hands-on course equips MedTech professionals with a rigorous approach to diagnosing and overcoming access barriers - so that impactful technologies reach the right patients, faster. Anchored in the 4A–5P model, participants learn to analyse access challenges through Availability, Affordability, Awareness, and Adoption, and to activate the levers of Policy, Partnerships, Process, People, and Product. Through a real-world case deep dive and AI-assisted data exploration, participants will map access pathways for their own portfolios, simulate bottleneck resolution under real constraints, and leave with an actionable Access Acceleration Plan ready for execution.
LEARNING OUTCOMES
By the end of the course, participants will be able to:
- Apply the 4A–5P framework to systematically diagnose access gaps and prioritize interventions.
- Use AI-assisted analysis to synthesize market, clinical, and policy data for access decision-making.
- Map stakeholders and influence networks to accelerate policy, adoption, and reimbursement progress.
- Design and stress-test solutions to bottlenecks within resource, regulatory, and policy constraints.
- Build an integrated Access Acceleration Plan with clear initiatives, owners, timelines, and metrics.
COURSE FORMAT
- Interactive lectures and facilitated discussions
- Case-based learning with data exploration
- Team-based simulations and solution pitches
- Guided workshops with templates and coaching
- Peer feedback and faculty perspectives on emerging trends
WHO SHOULD ATTEND
This course is ideal for forward-thinking senior leaders and decision-makers in MedTech, especially those in:
- Product, market access, medical affairs, and commercial leads in MedTech
- Health economics, policy, and reimbursement specialists
- Country/region managers and cross-functional team leaders driving market expansion
- Innovators and teams preparing for launch or scaling in emerging and developed markets
If you're ready to drive bold change and shape the future of healthcare access, this course is for you!
QUOTE BY COURSE DIRECTOR
“Access innovation is the next frontier of MedTech transformation—where commercial growth meets societal impact. The 4A model enables teams to see beyond technology and re-engineer the entire delivery ecosystem for speed, scale, and equity.”
- Adj. Assoc Prof Alok Mishra
|
MEET YOUR COURSE DIRECTORS
|
|
Adjunct Associate Professor Alok MISHRA
Commercial Discovery Lead and Industry Mentor, Duke-NUS Health Innovator Programme (D-HIP), Duke-NUS Medical School
Ex-J&J Medical APAC
|
|
A/Prof Alok Mishra is a seasoned healthcare executive with two decades at Johnson & Johnson Medical Asia Pacific, where he served in roles such as Regional VP Marketing & Business Development, Managing Director for Singapore and India, and Area VP for South Asia. He holds a Master’s in Pharmacy and an MBA from IIM Ahmedabad, beginning his marketing career with multinational firms in India and the Middle East. His contributions were recognized with a Lifetime Achievement Award in 2016 by the Department of Pharmaceutical Sciences at Dr Harisingh Gour Vishwavidyalaya, Sagar, India.
He is adjunct faculty at Singapore Management University’s MBA Programme and Duke-NUS Medical School, and is affiliated with the Asia School of Business Advisory Council and Singapore Stanford Biodesign as faculty and mentor. His expertise spans pharmaceuticals, consumer health, and medical devices, and he has held leadership roles in industry bodies including the Singapore Manufacturing Association and India Business Group. He chaired the Medical Technology & Life Sciences Industry Group at the Singapore Manufacturing Federation and previously served as Chairman of the Medical Technology Standards Committee of the Standards Council and the Medical Technology Group at the Confederation of Indian Industry (CII).
|
|
Dr Bipin BHOLA
Assistant Professor, Office of Innovation & Entrepreneurship, Duke-NUS Medical School
Curriculum Lead, Duke-NUS Health Innovator Programme (D-HIP)
Group CEO, Kaleidoscope Therapy Group
Ex-Jumpstart, SingHealth Innovation
|
|
Dr Bipin Bhola is a purpose-driven HealthTech leader and innovator, currently Group CEO and Partner of Kaleidoscope Therapy Group, a pediatric therapy company serving children with neurodevelopmental differences. He oversees 35 staff across three clinics and a digital home-based platform, serving over 1,000 clients annually and generating more than $4 million in yearly revenue. With 16+ years in healthcare across R&D, product development, strategic marketing, capital raising, alliances, stakeholder management, and venture creation, he also consults for the Department of Ophthalmology at National University Hospital, advising on strategy, fundraising, and commercialization. In academia, he is the pioneer Curriculum Lead for the Duke-NUS Health Innovator Programme.
Dr Bhola has shaped Singapore’s healthcare innovation ecosystem through leadership roles including establishing and operationalizing JUMPstart, a first-of-its-kind university-based national MedTech commercialization initiative managing 30+ companies. As Assistant Director at SingHealth’s Office for Innovation, he oversaw innovation across 14 institutes and built enabling infrastructure with SingHealth and Duke-NUS. At the National University of Singapore’s GRIP, he serves as a MedTech Track Consultant, guiding teams from startup formation to capital raising, contributing to the successful commercialization of more than five products in major markets. He holds a PhD and MS in Electrical Engineering (Applied Physics) from the University of Southern California and an MBA in Marketing and Strategy from Singapore Management University.
|
REFUND POLICY
• 100% refund if notified 14 business day before course/workshop start.
• 50% if notified during 1 to 13 business days.
• 0% on course start day onwards.
CONNECT WITH US!
Email: oie@duke-nus.edus.sg
Details
Certificate of Attendance will be issued
Standard Fees: SGD1000
Early Bird Fees (Purchased before 23rd Dec 2025): SGD900
(All prices indicated are before GST)
For Group signups, please email us at lifelonglearning@duke-nus.edu.sg for SGD900/pax (min 3pax)
TARGET AUDIENCE
This course is ideal for forward-thinking senior leaders and decision-makers in MedTech, especially those in:
- Product, market access, medical affairs, and commercial leads in MedTech
- Health economics, policy, and reimbursement specialists
- Country/region managers and cross-functional team leaders driving market expansion
- Innovators and teams preparing for launch or scaling in emerging and developed markets
